Supplementation with Red Wine Extract Increases Insulin Sensitivity and Peripheral Blood Mononuclear Sirt1 Expression in Nondiabetic Humans.
AMP-Activated Protein Kinases
/ genetics
Adult
Aged
Alanine Transaminase
/ blood
Aspartate Aminotransferases
/ blood
Biomarkers
/ blood
Blood Glucose
/ drug effects
Female
Humans
Insulin Resistance
Interleukin-6
/ blood
Leukocytes, Mononuclear
/ drug effects
Lipid Metabolism
/ drug effects
Male
Middle Aged
Polyphenols
/ pharmacology
Resveratrol
/ pharmacology
Sirtuin 1
/ genetics
THP-1 Cells
Triglycerides
/ blood
Wine
/ analysis
Young Adult
gamma-Glutamyltransferase
/ blood
Sirt1
insulin sensitivity
polyphenols
red wine extract
resveratrol
Journal
Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595
Informations de publication
Date de publication:
12 Oct 2020
12 Oct 2020
Historique:
received:
22
08
2020
revised:
28
09
2020
accepted:
09
10
2020
entrez:
15
10
2020
pubmed:
16
10
2020
medline:
13
4
2021
Statut:
epublish
Résumé
The aim of this study was to investigate the effects of dietary supplementation with a nonalcoholic red wine extract (RWE), including resveratrol and polyphenols, on insulin sensitivity and Sirt1 expression in nondiabetic humans. The present study was a single-arm, open-label and prospective study. Twelve subjects received supplementation with RWE, including 19.2 mg resveratrol and 136 mg polyphenols, daily for 8 weeks. After 8 weeks, metabolic parameters, including glucose/lipid metabolism and inflammatory markers, were evaluated. mRNA expression of Sirt1 was evaluated in isolated peripheral blood mononuclear cells (PBMNCs). Additionally, Sirt1 and phosphorylated AMP-activated kinase (p-AMPK) expression were evaluated in cultured human monocytes (THP-1 cells). Supplementation with RWE for 8 weeks decreased the homeostasis model assessment for insulin resistance (HOMA-IR), which indicates an increase in insulin sensitivity. Serum low-density lipoprotein-cholesterol (LDL-C), triglyceride (TG) and interleukin-6 (IL-6) were significantly decreased by RWE supplementation for 8 weeks. Additionally, Sirt1 mRNA expression in isolated PBMNCs was significantly increased after 8 weeks of RWE supplementation. Moreover, the rate of increase in Sirt1 expression was positively correlated with the rate of change in HOMA-IR. The administration of RWE increased Sirt1 and p-AMPK expression in cultured THP-1 cells. Supplementation with RWE improved metabolism, such as insulin sensitivity, lipid profile and inflammation, in humans. Additionally, RWE supplementation induced an increase in Sirt1 expression in PBMNCs, which may be associated with an improvement in insulin sensitivity.
Identifiants
pubmed: 33053742
pii: nu12103108
doi: 10.3390/nu12103108
pmc: PMC7600896
pii:
doi:
Substances chimiques
Biomarkers
0
Blood Glucose
0
Interleukin-6
0
Polyphenols
0
Triglycerides
0
gamma-Glutamyltransferase
EC 2.3.2.2
Aspartate Aminotransferases
EC 2.6.1.1
Alanine Transaminase
EC 2.6.1.2
AMP-Activated Protein Kinases
EC 2.7.11.31
SIRT1 protein, human
EC 3.5.1.-
Sirtuin 1
EC 3.5.1.-
Resveratrol
Q369O8926L
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Science. 2009 Jul 10;325(5937):201-4
pubmed: 19590001
Clin Hemorheol Microcirc. 2012;50(3):179-87
pubmed: 22240353
Crit Rev Food Sci Nutr. 2019;59(1):59-71
pubmed: 28799785
Oxid Med Cell Longev. 2017;2017:5812401
pubmed: 28894509
Cell. 2015 Mar 26;161(1):106-118
pubmed: 25815989
Nature. 2000 Feb 17;403(6771):795-800
pubmed: 10693811
Biochem Biophys Res Commun. 2012 Oct 12;427(1):191-6
pubmed: 22995302
Diabetes. 2010 Apr;59(4):1006-15
pubmed: 20068143
Circulation. 2019 Sep 10;140(11):e596-e646
pubmed: 30879355
Lancet. 1992 Jun 20;339(8808):1523-6
pubmed: 1351198
Nutrients. 2012 Jul;4(7):759-81
pubmed: 22852062
Mol Cell Biol. 2009 Mar;29(5):1363-74
pubmed: 19103747
Nutrients. 2017 Oct 18;9(10):
pubmed: 29057795
Nutrients. 2018 Oct 29;10(11):
pubmed: 30380657
Nitric Oxide. 2012 Feb 15;26(2):102-10
pubmed: 22245452
Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):639-47
pubmed: 24552647
Molecules. 2018 Jul 11;23(7):
pubmed: 29997312
J Am Coll Cardiol. 2006 Jan 17;47(2):398-402
pubmed: 16412867
Nature. 2003 Sep 11;425(6954):191-6
pubmed: 12939617
J Diabetes. 2016 May;8(3):324-35
pubmed: 25850408
Clin Nutr. 2013 Apr;32(2):200-6
pubmed: 22999066
Molecules. 2019 Oct 08;24(19):
pubmed: 31597344
J Biol Chem. 2010 Oct 29;285(44):33959-70
pubmed: 20817729
Cell Metab. 2009 Nov;10(5):392-404
pubmed: 19883617
Mol Cell Biol. 2010 Oct;30(19):4712-21
pubmed: 20647536
Cell Metab. 2007 Oct;6(4):307-19
pubmed: 17908559
Braz J Med Biol Res. 2014 Aug;47(8):697-705
pubmed: 25003545
Lancet Diabetes Endocrinol. 2019 Sep;7(9):673-683
pubmed: 31303390
Biochim Biophys Acta. 2013 Oct;1830(10):4820-7
pubmed: 23800577
Science. 2004 Jul 16;305(5682):390-2
pubmed: 15205477
J Biol Chem. 2007 Nov 23;282(47):34356-64
pubmed: 17901049
J Clin Invest. 1995 May;95(5):2409-15
pubmed: 7738205
Nutrients. 2019 Jun 16;11(6):
pubmed: 31208133
Mol Cell. 2007 Oct 12;28(1):91-106
pubmed: 17936707
Mol Cell Endocrinol. 2011 Mar 30;335(2):166-76
pubmed: 21241768
Am J Physiol Endocrinol Metab. 2010 Mar;298(3):E419-28
pubmed: 19996381
Diabetes. 2013 Apr;62(4):1186-95
pubmed: 23193181
Diabetes. 2011 Dec;60(12):3235-45
pubmed: 22110092
Virus Res. 2015 Jul 2;205:63-72
pubmed: 26031763
Eur J Nutr. 2020 Apr;59(3):1263-1271
pubmed: 31732850
Mol Neurobiol. 2019 Aug;56(8):5556-5567
pubmed: 30649713
Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6659-63
pubmed: 15096581
Ann N Y Acad Sci. 2011 Jan;1215:117-22
pubmed: 21261649
Cell Metab. 2011 Nov 2;14(5):612-22
pubmed: 22055504
Front Endocrinol (Lausanne). 2019 Mar 27;10:187
pubmed: 30972029
Clin Sci (Lond). 2012 Oct;123(8):499-507
pubmed: 22563892
Circulation. 2002 Sep 24;106(13):1614-7
pubmed: 12270851
Life Sci. 2020 Oct 15;259:118173
pubmed: 32750437
Curr Drug Targets. 2013 Jun 1;14(6):622-36
pubmed: 23445543
Cell Metab. 2012 Nov 7;16(5):658-64
pubmed: 23102619
Metabolism. 2005 Mar;54(3):306-13
pubmed: 15736107